291 related articles for article (PubMed ID: 17318067)
1. The association among C4d staining in renal transplant biopsies, the production of donor-specific HLA antibodies, and graft outcome.
Howie AJ
Transplantation; 2007 Feb; 83(4):373-4. PubMed ID: 17318067
[No Abstract] [Full Text] [Related]
2. Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome.
Worthington JE; McEwen A; McWilliam LJ; Picton ML; Martin S
Transplantation; 2007 Feb; 83(4):398-403. PubMed ID: 17318071
[TBL] [Abstract][Full Text] [Related]
3. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of C4d deposition in stable renal allografts in the early post-transplantation period.
Yoon HE; Kim SH; Kim JY; Oh EJ; Park SC; Choi BS; Choi YJ; Moon IS; Kim YS; Yang CW
Clin Transplant; 2009; 23(6):812-8. PubMed ID: 19191803
[TBL] [Abstract][Full Text] [Related]
5. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
6. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
[TBL] [Abstract][Full Text] [Related]
7. C4d in pediatric renal allograft biopsies: a marker for negative outcome in steroid-resistant rejection.
Vargha R; Mueller T; Arbeiter K; Regele H; Exner M; Csaicsich D; Aufricht C
Pediatr Transplant; 2006 Jun; 10(4):449-53. PubMed ID: 16712602
[TBL] [Abstract][Full Text] [Related]
8. Blood group Lewis alloantibodies cause antibody-mediated rejection in renal transplant recipients.
Boratyńska M; Banasik M; Hałoń A; Patrzałek D; Klinger M
Transplant Proc; 2007 Nov; 39(9):2711-4. PubMed ID: 18021965
[TBL] [Abstract][Full Text] [Related]
9. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.
Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD
J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
Rose ML; Smith JD
Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
[TBL] [Abstract][Full Text] [Related]
11. Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival.
Saidman S
Transplant Proc; 2007 Apr; 39(3):744-6. PubMed ID: 17445587
[TBL] [Abstract][Full Text] [Related]
12. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
[TBL] [Abstract][Full Text] [Related]
13. Distribution of donor-specific antibodies in the cortex and the medulla of renal transplants with chronic allograft nephropathy.
Bocrie O; Hussein Aly AA; Guignier F; Funes de la Vega M; Rifle G; Mousson C; Martin L
Transpl Immunol; 2007 Apr; 17(3):227-9. PubMed ID: 17331852
[TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated rejection.
Akalin E; Watschinger B
Semin Nephrol; 2007 Jul; 27(4):393-407. PubMed ID: 17616272
[TBL] [Abstract][Full Text] [Related]
15. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
[TBL] [Abstract][Full Text] [Related]
16. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
Li X; Ishida H; Yamaguchi Y; Tanabe K
Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
[TBL] [Abstract][Full Text] [Related]
17. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
[TBL] [Abstract][Full Text] [Related]
18. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining.
Akalin E; Dinavahi R; Dikman S; de Boccardo G; Friedlander R; Schroppel B; Sehgal V; Bromberg JS; Heeger P; Murphy B
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1261-7. PubMed ID: 17942771
[TBL] [Abstract][Full Text] [Related]
19. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
20. C4d-positive chronic rejection: a frequent entity with a poor outcome.
David-Neto E; Prado E; Beutel A; Ventura CG; Siqueira SA; Hung J; Lemos FB; de Souza NA; Nahas WC; Ianhez LE; David DR
Transplantation; 2007 Dec; 84(11):1391-8. PubMed ID: 18091514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
